AbbVie Hits Hetero USA With 2nd Suit Over Norvir Generic
AbbVie Inc. on Thursday sued Hetero USA Inc. in Delaware federal court, accusing the drugmaker of infringing two patents with its planned generic version of HIV treatment Norvir....To view the full article, register now.
Already a subscriber? Click here to view full article